OUTCOMES OF DOSE ESCALATION AND DRUG LEVEL MONITORING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB

被引:0
|
作者
Scoville, Elizabeth A.
Izmaylov, Michelle L.
Bennett, Audrey
Evers, Lauren
Annis, Kim
Garrett, Ailish
Duley, Caroline
Adams, Dawn W.
Dalal, Robin L.
Beaulieu, Dawn
Schwartz, David A.
Horst, Sara N.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mo1862
引用
收藏
页码:S829 / S830
页数:2
相关论文
共 50 条
  • [41] Azathioprine dose escalation in inflammatory bowel disease
    Rayner, CK
    Hart, AL
    Hayward, CMM
    Emmanuel, AV
    Kamm, MA
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (01) : 65 - 71
  • [42] Assessment of Vedolizumab Disease-Drug-Drug Interaction in Patients With Inflammatory Bowel Diseases
    Sun, Wan
    Lirio, Richard A.
    Schneider, Jennifer
    Aubrecht, Jiri
    Kadali, Harisha
    Baratta, Mike
    Gulati, Parul
    Suri, Ajit
    Lin, Tiffany
    Vasudevan, Raghavan
    Rosario, Maria
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S451 - S452
  • [43] Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease: current data and future directions
    Ward, Mark G.
    Sparrow, Miles P.
    Roblin, Xavier
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2018, 11
  • [44] Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overview
    Lieven Pouillon
    Séverine Vermeire
    Peter Bossuyt
    [J]. BMC Medicine, 17
  • [45] Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overview
    Pouillon, Lieven
    Vermeire, Severine
    Bossuyt, Peter
    [J]. BMC MEDICINE, 2019, 17 (1)
  • [46] Update on TDM (Therapeutic Drug Monitoring) with Ustekinumab, Vedolizumab and Tofacitinib in Inflammatory Bowel Disease
    Restellini, Sophie
    Afif, Waqqas
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (06) : 1 - 16
  • [47] The Risk of Tuberculosis in Patients With Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab in Korea
    Choi, Myeong Geun
    Ye, Byong Duk
    Yang, Suk-Kyun
    Shim, Tae Sun
    Jo, Kyung-Wook
    Park, Sang Hyoung
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (14)
  • [48] Surgical outcomes of patients treated with ustekinumab vs. vedolizumab in inflammatory bowel disease: a matched case analysis
    Novello, Matteo
    Stocchi, Luca
    Holubar, Stefan
    Shawki, Sherief
    Lipman, Jeremy
    Gorgun, Emre
    Hull, Tracy
    Steele, Scott R.
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2019, 34 (03) : 451 - 457
  • [49] Surgical outcomes of patients treated with ustekinumab vs. vedolizumab in inflammatory bowel disease: a matched case analysis
    Matteo Novello
    Luca Stocchi
    Stefan Holubar
    Sherief Shawki
    Jeremy Lipman
    Emre Gorgun
    Tracy Hull
    Scott R. Steele
    [J]. International Journal of Colorectal Disease, 2019, 34 : 451 - 457
  • [50] Vedolizumab Drug Levels During Maintenance Therapy in Inflammatory Bowel Disease Patients
    Koduru, Pramoda
    Morrill, Amanda
    Abraham, Bincy
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 : S63 - S64